ImmPort Study ID	PubMed	Study Title	PI	Biosample ID	Experiment ID	Cohort	Repository Accession	Type	Biosample Name	Biosample Description	Species	Strain	Cancer Type
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473293	GSE108131	prostate tumor tissue	GSM2890468	None	W4336 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4336 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473294	GSE108131	prostate tumor tissue	GSM2890469	None	W4399 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4399 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473295	GSE108131	prostate tumor tissue	GSM2890470	None	W4513 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4513 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473296	GSE108131	prostate tumor tissue	GSM2890471	None	W4512 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4512 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473297	GSE108131	prostate tumor tissue	GSM2890472	None	W4438 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4438 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473298	GSE108131	prostate tumor tissue	GSM2890473	None	W7822 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W7822 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473299	GSE108131	prostate tumor tissue	GSM2890474	None	W4218 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4218 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473300	GSE108131	prostate tumor tissue	GSM2890475	None	W4498 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4498 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473301	GSE108131	prostate tumor tissue	GSM2890476	None	W4455 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4455 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473302	GSE108131	prostate tumor tissue	GSM2890477	None	W4347 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4347 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473303	GSE108131	prostate tumor tissue	GSM2890478	None	W4471 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4471 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473304	GSE108131	prostate tumor tissue	GSM2890479	None	W4199 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4199 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473305	GSE108131	prostate tumor tissue	GSM2890480	None	W4511 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4511 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473306	GSE108131	prostate tumor tissue	GSM2890481	None	W4443 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4443 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473307	GSE108131	prostate tumor tissue	GSM2890482	None	W4434 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4434 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473308	GSE108131	prostate tumor tissue	GSM2890483	None	W4495 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4495 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473309	GSE108131	prostate tumor tissue	GSM2890484	None	W4431 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4431 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473310	GSE108131	prostate tumor tissue	GSM2890485	None	W4489 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4489 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473311	GSE108131	prostate tumor tissue	GSM2890486	None	W4454 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4454 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473312	GSE108131	prostate tumor tissue	GSM2890487	None	W4487 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4487 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473313	GSE108131	prostate tumor tissue	GSM2890488	None	W4370 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4370 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473314	GSE108131	prostate tumor tissue	GSM2890489	None	W4071 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4071 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473315	GSE108131	prostate tumor tissue	GSM2890490	None	W4508 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4508 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473316	GSE108131	prostate tumor tissue	GSM2890491	None	W1118 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1118 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473317	GSE108131	prostate tumor tissue	GSM2890492	None	W1512 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1512 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473318	GSE108131	prostate tumor tissue	GSM2890493	None	W4426 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4426 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473319	GSE108131	prostate tumor tissue	GSM2890494	None	W899 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W899 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473320	GSE108131	prostate tumor tissue	GSM2890495	None	W1154 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1154 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473321	GSE108131	prostate tumor tissue	GSM2890496	None	W4491 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4491 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473322	GSE108131	prostate tumor tissue	GSM2890497	None	W1915 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1915 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473323	GSE108131	prostate tumor tissue	GSM2890498	None	W4441 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4441 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473324	GSE108131	prostate tumor tissue	GSM2890499	None	W4548 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4548 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473325	GSE108131	prostate tumor tissue	GSM2890500	None	W370 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W370 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473326	GSE108131	prostate tumor tissue	GSM2890501	None	W4437 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4437 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473327	GSE108131	prostate tumor tissue	GSM2890502	None	W4422 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4422 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473328	GSE108131	prostate tumor tissue	GSM2890503	None	W1052 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1052 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473329	GSE108131	prostate tumor tissue	GSM2890504	None	W897 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W897 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473330	GSE108131	prostate tumor tissue	GSM2890505	None	W4296 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4296 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473331	GSE108131	prostate tumor tissue	GSM2890506	None	W1050 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1050 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473332	GSE108131	prostate tumor tissue	GSM2890507	None	W4379 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4379 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473333	GSE108131	prostate tumor tissue	GSM2890508	None	W4429 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4429 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473334	GSE108131	prostate tumor tissue	GSM2890509	None	W1462 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1462 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473335	GSE108131	prostate tumor tissue	GSM2890510	None	W4549 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4549 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473336	GSE108131	prostate tumor tissue	GSM2890511	None	W4509 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4509 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473337	GSE108131	prostate tumor tissue	GSM2890512	None	W247 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W247 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473338	GSE108131	prostate tumor tissue	GSM2890513	None	W1790 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1790 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473339	GSE108131	prostate tumor tissue	GSM2890514	None	W4397 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4397 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473340	GSE108131	prostate tumor tissue	GSM2890515	None	W4403 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4403 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473341	GSE108131	prostate tumor tissue	GSM2890516	None	W4288 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4288 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473342	GSE108131	prostate tumor tissue	GSM2890517	None	W4165 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4165 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473343	GSE108131	prostate tumor tissue	GSM2890518	None	W4226 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4226 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473344	GSE108131	prostate tumor tissue	GSM2890519	None	W4419 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4419 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473345	GSE108131	prostate tumor tissue	GSM2890520	None	W353 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W353 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473346	GSE108131	prostate tumor tissue	GSM2890521	None	W4216 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4216 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473347	GSE108131	prostate tumor tissue	GSM2890522	None	W4126 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4126 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473348	GSE108131	prostate tumor tissue	GSM2890523	None	W4179 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4179 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473349	GSE108131	prostate tumor tissue	GSM2890524	None	W4173 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4173 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473350	GSE108131	prostate tumor tissue	GSM2890525	None	W1514 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1514 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473351	GSE108131	prostate tumor tissue	GSM2890526	None	W4209 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4209 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473352	GSE108131	prostate tumor tissue	GSM2890527	None	W4125 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4125 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473353	GSE108131	prostate tumor tissue	GSM2890528	None	W4181 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4181 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473354	GSE108131	prostate tumor tissue	GSM2890529	None	W4178 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4178 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473355	GSE108131	prostate tumor tissue	GSM2890530	None	W4351 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4351 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473356	GSE108131	prostate tumor tissue	GSM2890531	None	W4183 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4183 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473357	GSE108131	prostate tumor tissue	GSM2890532	None	W4292 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4292 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473358	GSE108131	prostate tumor tissue	GSM2890533	None	W4077 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4077 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473359	GSE108131	prostate tumor tissue	GSM2890534	None	W4078 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4078 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473360	GSE108131	prostate tumor tissue	GSM2890535	None	W4063 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4063 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473361	GSE108131	prostate tumor tissue	GSM2890536	None	W4072 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4072 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473362	GSE108131	prostate tumor tissue	GSM2890537	None	W4076 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4076 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473363	GSE108131	prostate tumor tissue	GSM2890538	None	W4065 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4065 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473364	GSE108131	prostate tumor tissue	GSM2890539	None	W4079 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4079 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473365	GSE108131	prostate tumor tissue	GSM2890540	None	W4070 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4070 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473366	GSE108131	prostate tumor tissue	GSM2890541	None	W4424 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4424 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473367	GSE108131	prostate tumor tissue	GSM2890542	None	W4378 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4378 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473368	GSE108131	prostate tumor tissue	GSM2890543	None	W4360 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4360 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473369	GSE108131	prostate tumor tissue	GSM2890544	None	W4219 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4219 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473370	GSE108131	prostate tumor tissue	GSM2890545	None	W242 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W242 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473371	GSE108131	prostate tumor tissue	GSM2890546	None	W4350 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4350 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473372	GSE108131	prostate tumor tissue	GSM2890547	None	W4421 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4421 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473373	GSE108131	prostate tumor tissue	GSM2890548	None	W4363 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4363 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473374	GSE108131	prostate tumor tissue	GSM2890549	None	W4414 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4414 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473375	GSE108131	prostate tumor tissue	GSM2890550	None	W78022 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W78022 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473376	GSE108131	prostate tumor tissue	GSM2890551	None	W4064 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4064 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473377	GSE108131	prostate tumor tissue	GSM2890552	None	W4427 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4427 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473378	GSE108131	prostate tumor tissue	GSM2890553	None	W4381 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4381 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473379	GSE108131	prostate tumor tissue	GSM2890554	None	W4492 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4492 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473380	GSE108131	prostate tumor tissue	GSM2890555	None	W244 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W244 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473381	GSE108131	prostate tumor tissue	GSM2890556	None	W4386 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4386 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473382	GSE108131	prostate tumor tissue	GSM2890557	None	W1182 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1182 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473383	GSE108131	prostate tumor tissue	GSM2890558	None	W4376 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4376 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473384	GSE108131	prostate tumor tissue	GSM2890559	None	W4394 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4394 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473385	GSE108131	prostate tumor tissue	GSM2890560	None	W4517 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4517 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473386	GSE108131	prostate tumor tissue	GSM2890561	None	W4120 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4120 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473387	GSE108131	prostate tumor tissue	GSM2890562	None	W4362 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4362 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473388	GSE108131	prostate tumor tissue	GSM2890563	None	W4180 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4180 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473389	GSE108131	prostate tumor tissue	GSM2890564	None	W4417 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4417 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473390	GSE108131	prostate tumor tissue	GSM2890565	None	W992 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W992 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473391	GSE108131	prostate tumor tissue	GSM2890566	None	W4356 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4356 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473392	GSE108131	prostate tumor tissue	GSM2890567	None	W4202 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4202 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473393	GSE108131	prostate tumor tissue	GSM2890568	None	W5004 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W5004 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473394	GSE108131	prostate tumor tissue	GSM2890569	None	W5003 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W5003 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473395	GSE108131	prostate tumor tissue	GSM2890570	None	W5000 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W5000 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473396	GSE108131	prostate tumor tissue	GSM2890571	None	W4392 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4392 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473397	GSE108131	prostate tumor tissue	GSM2890572	None	W1796 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1796 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473398	GSE108131	prostate tumor tissue	GSM2890573	None	W1702 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1702 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473399	GSE108131	prostate tumor tissue	GSM2890574	None	W462 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W462 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473400	GSE108131	prostate tumor tissue	GSM2890575	None	W5001 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W5001 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473401	GSE108131	prostate tumor tissue	GSM2890576	None	W4182 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4182 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473402	GSE108131	prostate tumor tissue	GSM2890577	None	W1065 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1065 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473403	GSE108131	prostate tumor tissue	GSM2890578	None	W4162 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W4162 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473404	GSE108131	prostate tumor tissue	GSM2890579	None	W407 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W407 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473405	GSE108131	prostate tumor tissue	GSM2890580	None	W5005 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W5005 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473406	GSE108131	prostate tumor tissue	GSM2890581	None	W5002 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W5002 RNA-seq	Prostate_Adenocarcinoma
GSE108131	29890952	Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.	None	SRX3473407	GSE108131	prostate tumor tissue	GSM2890582	None	W1103 RNA-seq	F2 offspring from (TRAMP x WSB/EiJ) cross	Mouse	W1103 RNA-seq	Prostate_Adenocarcinoma
